Park KT - Search Results

1

Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.

Suh JH, Degagné É, Gleghorn EE, Setty M, Rodriguez A, Park KT, Verstraete SG, Heyman MB, Patel AS, Irek M, Gildengorin GL, Hubbard NE, Borowsky AD, Saba JD. Suh JH, et al. Among authors: park kt. Inflamm Bowel Dis. 2018 May 18;24(6):1321-1334. doi: 10.1093/ibd/izy007. Inflamm Bowel Dis. 2018. PMID: 29788359 Free PMC article.

2

Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review.

Park KT, Bass D. Park KT, et al. Inflamm Bowel Dis. 2011 Jul;17(7):1603-9. doi: 10.1002/ibd.21488. Epub 2010 Nov 4. Inflamm Bowel Dis. 2011. PMID: 21053357 Review.

3

Non-drug costs associated with outpatient infliximab administration in pediatric inflammatory bowel disease.

Wu M, Sin A, Nishioka F, Park KT. Wu M, et al. Among authors: park kt. Inflamm Bowel Dis. 2013 Jun;19(7):1514-7. doi: 10.1097/MIB.0b013e318281f4f1. Inflamm Bowel Dis. 2013. PMID: 23567783 Free PMC article.

4

Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel disease.

Park KT, Crandall WV, Fridge J, Leibowitz IH, Tsou M, Dykes DM, Hoffenberg EJ, Kappelman MD, Colletti RB. Park KT, et al. Inflamm Bowel Dis. 2014 May;20(5):946-51. doi: 10.1097/01.MIB.0000441349.40193.aa. Inflamm Bowel Dis. 2014. PMID: 24451222 Free PMC article. Review.

5

Utilization trends of anti-TNF agents and health outcomes in adults and children with inflammatory bowel diseases: a single-center experience.

Park KT, Sin A, Wu M, Bass D, Bhattacharya J. Park KT, et al. Inflamm Bowel Dis. 2014 Jul;20(7):1242-9. doi: 10.1097/MIB.0000000000000061. Inflamm Bowel Dis. 2014. PMID: 24846718 Free PMC article.

6

Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.

Sin AT, Damman JL, Ziring DA, Gleghorn EE, Garcia-Careaga MG, Gugig RR, Hunter AK, Burgis JC, Bass DM, Park KT. Sin AT, et al. Among authors: park kt. Inflamm Bowel Dis. 2015 Jun;21(6):1368-77. doi: 10.1097/MIB.0000000000000374. Inflamm Bowel Dis. 2015. PMID: 25839776 Free PMC article.

7

Spanish and English Language Symposia to Enhance Activation in Pediatric Inflammatory Bowel Disease.

Martin M, Garcia M, Christofferson M, Bensen R, Yeh AM, Park KT. Martin M, et al. Among authors: park kt. J Pediatr Gastroenterol Nutr. 2016 Nov;63(5):508-511. doi: 10.1097/MPG.0000000000001191. J Pediatr Gastroenterol Nutr. 2016. PMID: 27031374 Free PMC article.

8

Premedication Use Before Infliximab Administration: A Cross-sectional Analysis.

Picoraro J, Winberry G, Siegel CA, El-Matary W, Moses J, Grossman A, Park KT. Picoraro J, et al. Among authors: park kt. Inflamm Bowel Dis. 2017 Jan;23(1):174-180. doi: 10.1097/MIB.0000000000001002. Inflamm Bowel Dis. 2017. PMID: 28002131 Free PMC article. Review.

9

Path of Interchangeability of Biosimilars in Pediatric Inflammatory Bowel Disease: Quality Before Cost Savings.

Patel D, Park KT. Patel D, et al. Among authors: park kt. J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):134-136. doi: 10.1097/MPG.0000000000001572. J Pediatr Gastroenterol Nutr. 2017. PMID: 28319603 Free PMC article.

10

Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.

Heida A, Park KT, van Rheenen PF. Heida A, et al. Among authors: park kt. Inflamm Bowel Dis. 2017 Jun;23(6):894-902. doi: 10.1097/MIB.0000000000001082. Inflamm Bowel Dis. 2017. PMID: 28511198 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters